NRx Pharmaceuticals, Inc.NRXPNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-7.88%
↑ 53% above average
Average (32q)
-16.79%
Historical baseline
Range
High:100.00%
Low:-321.97%
Volatility
-2512.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -7.88% |
| Q2 2025 | 3.04% |
| Q1 2025 | -5.86% |
| Q4 2024 | -20.25% |
| Q3 2024 | 57.13% |
| Q2 2024 | -17.54% |
| Q1 2024 | -36.13% |
| Q4 2023 | 24.14% |
| Q3 2023 | 26.83% |
| Q2 2023 | 15.87% |
| Q1 2023 | 4.58% |
| Q4 2022 | -8.17% |
| Q3 2022 | 4.78% |
| Q2 2022 | 38.87% |
| Q1 2022 | 70.35% |
| Q4 2021 | -163.57% |
| Q3 2021 | -17.42% |
| Q2 2021 | -241.65% |
| Q1 2021 | 53.78% |
| Q4 2020 | -34.06% |
| Q3 2020 | -321.97% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | -4.18% |
| Q3 2019 | -4.15% |
| Q2 2019 | -7.98% |
| Q1 2019 | 49.38% |
| Q4 2018 | -46.20% |
| Q3 2018 | 18.97% |
| Q2 2018 | -41.29% |
| Q1 2018 | -43.56% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |